India to build future-ready drug regulatory framework to accelerate healthcare innovation, Says J P Nadda Read more
Trump’s proposed generic drug tariffs trigger caution, industry sees limited near-term impact Read more
PHARMEXCIL engages in high-level meetings to discuss roadmap for India’s generic pharma exports Read more
Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026 Read more